Joseph Mills
SVS responds to New York Times article on overuse of vascular...
In an official Society response, SVS President Joseph Mills, MD, tackles recent coverage in the mainstream media of inappropriateness in vascular care.
There have been...
‘Proceed cautiously in use of DCBs in CLTI patients with advanced...
The last several years have seen ongoing controversy and debate about the risks and benefits of paclitaxel-coated devices (PCDs) for patients with peripheral arterial...
Endovascular Therapy First for All CLI?
The Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease (TASC I), published in January 2001, resulted from cooperation between fourteen medical, radiological...